NASDAQ:CAI | Free Cash Flow | Caris Life Sciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$32.88M$10.34M$22.53M
2025-12-31$44.78M$5.09M$39.69M48.43%
2025-03-31-$31.34M$2.69M-$34.03M
2024-12-31-$38.92M$2.29M-$41.21M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$83.16M$16.26M$66.9M
2024-12-31-$245.2M$8.44M-$253.64M
2023-12-31-$276.1M$22.32M-$298.42M